Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms ZIKV NS4B-C100S |
Target |
Action inhibitors |
Mechanism NS4B inhibitors(Nonstructural protein 4B inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Zika Virus Infection | Preclinical | United States | 28 Nov 2019 |





